Medlive Technology Co., Ltd. — Board/Management Information 2023

Jun 12, 2023

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [119 x 52] intentionally omitted <==

Medlive Technology Co., Ltd. 醫脈通科技有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2192)

CHANGE OF JOINT COMPANY SECRETARY, AUTHORIZED REPRESENTATIVE AND PROCESS AGENT

The board of directors (the “ Board ”) of Medlive Technology Co., Ltd. (the “ Company ”) hereby announces that Ms. Szeto Kar Yee Cynthia (“ Ms. Szeto ”) has resigned from her positions as the joint company secretary of the Company (the “ Joint Company Secretary ”), an authorized representative of the Company under Rule 3.05 of the Rules Governing the Listing of Securities (the “ Listing Rules ”) on The Stock Exchange of Hong Kong Limited (the “ Stock Exchange ”) (the “ Authorized Representative ”) and the agent for the acceptance of service of process and notices on behalf of the Company in Hong Kong under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong) (the “ Process Agent ”) due to other work arrangements, with effect from 12 June 2023.

Ms. Szeto has confirmed that there is no disagreement with the Board and there are no matters that need to be brought to the attention of the shareholders of the Company or the Stock Exchange in relation to her resignation.

The Board is also pleased to announce that Ms. Chu Cheuk Ting (“ Ms. Chu ”) has been appointed by the Company as the Joint Company Secretary, the Authorized Representative and the Process Agent in place of Ms. Szeto, with effect from 12 June 2023. Ms. Yang Yanling (“ Ms. Yang ”) will continue to serve as the other Joint Company Secretary of the Company.

– 1 –

Ms. Chu currently serves as a manager of the listing services department of TMF Hong Kong Limited and is responsible for provision of corporate secretarial and compliance services to listed company clients. Ms. Chu has accumulated over 12 years of experience in the professional company secretarial field, and she is an associate member of both The Hong Kong Chartered Governance Institute and The Chartered Governance Institute in the United Kingdom.

Ms. Yang was appointed as a joint company secretary of the Company on 4 March 2021. Ms. Yang joined the Group in March 2018 and currently serves as a human resources manager of the Group and is in charge of the overall management of the human resources department and assists in the management of other operation departments including medical, design and creative departments. Before joining the Group, Ms. Yang served as human resources specialist in a few domestic companies. Ms. Yang obtained a bachelor’s degree in agriculture from Hebei North University (河北北方學院) in June 2013.

The Stock Exchange has granted a waiver to the Company from strict compliance with the requirements under Rules 3.28 and 8.17 of the Listing Rules on the of the Stock Exchange, for a period from 12 June 2023 to 14 July 2024 (the “ Waiver Period ”) in relation to Ms. Yang’s eligibility to act as the Joint Company Secretary on the conditions that (i) Ms. Yang must be assisted by Ms. Chu as a Joint Company Secretary during the Waiver Period and the waiver will be revoked if Ms. Chu ceases to be a Joint Company Secretary of the Company; and (ii) the waiver could be revoked if there are material breaches of the Listing Rules by the Company. Before the end of the Waiver Period, the Company will demonstrate and seek the Stock Exchange’s confirmation that Ms. Yang, having had the benefit of Ms. Chu’s assistance during the Waiver Period, has attained the relevant experience and is capable of discharging the functions of a company secretary under Rule 3.28 of the Listing Rules such that a further waiver will not be necessary.

The Board would like to take this opportunity to express its sincere gratitude to Ms. Szeto for her contribution to the Company during her tenure of services, and to express its welcome to Ms. Chu on her new appointment.

By order of the Board Medlive Technology Co., Ltd. Tian Liping Chairwoman and Chief Executive Officer

Hong Kong, 12 June 2023

As at the date of this announcement, the Board comprises Ms. Tian Liping, Mr. Tian Lixin, Mr. Tian Lijun and Ms. Zhou Xin as executive Directors; Mr. Eiji Tsuchiya and Mr. Kazutaka Kanairo as non-executive Directors; and Mr. Richard Yeh, Dr. Ma Jun and Ms. Wang Shan as independent non-executive Directors.

– 2 –